[Cryptosporidiosis. A rare infection in renal transplantation].
Franco
A
A
Rocamora
N
N
Merino
E
E
Paya
A
A
D000328:Adult; D000818:Animals; D001379:Azathioprine / Q000627:therapeutic use; D003457:Cryptosporidiosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D003458:Cryptosporidium / Q000302:isolation & purification; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D005773:Gastroscopy; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007411:Intestinal Diseases, Parasitic / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D007413:Intestinal Mucosa / Q000469:parasitology; D016030:Kidney Transplantation; D044342:Malnutrition / Q000209:etiology; D008775:Methylprednisolone / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D009894:Opportunistic Infections / Q000209:etiology*; D011183:Postoperative Complications / Q000209:etiology*; D015572:Spiramycin / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D015572:Spiramycin; D016572:Cyclosporine; D009173:Mycophenolic Acid; D001379:Azathioprine; D008775:Methylprednisolone